Buy Inotek Pharmaceuticals Stock | ITEK Stock Price & Latest News | Public.com
ITEK

Inotek Pharmaceuticals

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Inotek Pharmaceuticals (ITEK) stock trends here

    About ITEK

    Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.36
    -0.72
    -1.08
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.65

    Actual EPS
    Q1 2021

    Stats

    Market Cap$3,1B
    Volume388,56k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$67.48
    1 Year Low$9.01
    Open$51.94
    High$56.25
    Low$50.04

    Buy any stock with any amount of money.

    Download the App
    Download the app